Soncini D. P104 | Soluble BCMA mirrors bone marrow disease burden and predicts outcome in multiple myeloma patients: <a href="https://haematologica.org/search/search?query=D.+Soncini">D. Soncini</a>^1|2, <a href="https://haematologica.org/search/search?query=I.+Traverso">I. Traverso</a>¹, <a href="https://haematologica.org/search/search?query=G.+Giorgetti">G. Giorgetti</a>², <a href="https://haematologica.org/search/search?query=A.E.+Laserra">A.E. Laserra</a>¹, <a href="https://haematologica.org/search/search?query=E.+Catini">E. Catini</a>¹, <a href="https://haematologica.org/search/search?query=F.+Guolo">F. Guolo</a>^1|2, <a href="https://haematologica.org/search/search?query=M.+Garibotto">M. Garibotto</a>², <a href="https://haematologica.org/search/search?query=A.+Cagnetta">A. Cagnetta</a>², <a href="https://haematologica.org/search/search?query=R.M.+Lemoli">R.M. Lemoli</a>^1|2, <a href="https://haematologica.org/search/search?query=M.+Cea">M. Cea</a>^1|2 | <i>¹Clinic of Hematology, Department of Internal Medicine and Medical Specialties ^DiMI, University of Genoa; ²IRCCS Ospedale Policlinico San Martino</i&gt;. haematol [Internet]. 2026Mar.3 [cited 2026Mar.4];111(s1). Available from: https://haematologica.org/article/view/haematol.2026.s1.161